Glaucoma is one of the most common optic neuropathies,featuring progressive retinal ganglion cell damage and visual field loss(Tham et al.,2014;Xu et al.,2020).Currently,the only effective treatment for this condition...Glaucoma is one of the most common optic neuropathies,featuring progressive retinal ganglion cell damage and visual field loss(Tham et al.,2014;Xu et al.,2020).Currently,the only effective treatment for this condition is the reduction of intraocular pressure(IOP)(Palmberg,2001;Heijl et al.,2002).Canaloplasty is a proven bleb-independent surgery with good efficacy and safety profiles in primary open-angle glaucoma(POAG)(Gołaszewska et al.,2021).However,early transient postoperative IOP elevation has been reported in up to 30%of cases(Riva et al.,2019),similar to that commonly observed in other internal drainage glaucoma surgeries such as implantation using iStent(0%–21.0%),CyPass(10.8%),and Hydrus(4.8%–6.5%)(Lavia et al.,2017).展开更多
基金National Natural Science Foundation of China(No.82201177)Health Commission of Zhejiang Province(No.2023KY914)+5 种基金Key R&D Program of Zhejiang(No.2022C03112)National Key R&D Program of China(No.2020YFC2008200)Zhejiang Provincial National Science Foundation of China(No.LQ18H120010)Zhejiang Health Innovation Talents Program(No.2016025)Key Innovation and Guidance Program of the Eye Hospital,School of Ophthalmology&Optometry,Wenzhou Medical University(No.YNZD2201903)Wenzhou Municipal Technological Innovation Program of High-level Talents(No.604090352/577).
文摘Glaucoma is one of the most common optic neuropathies,featuring progressive retinal ganglion cell damage and visual field loss(Tham et al.,2014;Xu et al.,2020).Currently,the only effective treatment for this condition is the reduction of intraocular pressure(IOP)(Palmberg,2001;Heijl et al.,2002).Canaloplasty is a proven bleb-independent surgery with good efficacy and safety profiles in primary open-angle glaucoma(POAG)(Gołaszewska et al.,2021).However,early transient postoperative IOP elevation has been reported in up to 30%of cases(Riva et al.,2019),similar to that commonly observed in other internal drainage glaucoma surgeries such as implantation using iStent(0%–21.0%),CyPass(10.8%),and Hydrus(4.8%–6.5%)(Lavia et al.,2017).
